Enovis (ENOV) Current Deferred Revenue (2010 - 2016)
Enovis (ENOV) reported Current Deferred Revenue of $151.0 million for Q4 2016, down 22.57% year-over-year from $195.0 million in Q1 2016, and down 22.57% quarter-over-quarter from $195.0 million in Q4 2015.
Enovis (ENOV) Current Deferred Revenue (2010 - 2016) Analysis & Trends
Enovis (ENOV) has 4 years of Current Deferred Revenue data on file, last reported at $151.0 million in Q4 2016.
- Current Deferred Revenue for Q4 2016 came in at $151.0 million, down 22.57% year-over-year; the trailing twelve-month figure through Dec 2016 was $151.0 million (down 22.57% YoY), and the FY2016 annual result was $151.0 million, down 22.57% from the prior year.
- Current Deferred Revenue slipped to $151.0 million in Q4 2016 per ENOV's latest filing, from $195.0 million in the prior quarter.
- Over five years, Current Deferred Revenue peaked at $195.0 million in Q4 2015 and troughed at $151.0 million in Q4 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn |
| 10 | Enovis | 1.26 Bn | 1.23 Bn | 365.49 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2016 | 151.02 Mn |
| Dec 31, 2015 | 195.04 Mn |
| Dec 31, 2011 | 14.70 Mn |
| Sep 30, 2011 | 13.58 Mn |
| Jul 1, 2011 | 22.19 Mn |
| Dec 31, 2010 | 17.25 Mn |